ClinicalTrials.gg
CompletedNCT03838653Updated Feb 12, 2019

Influence of Tracheal-bronchial Anatomy Changes on Multi-detector Computed Tomography Scan of the Chest Upon Placement of Left-Sided Double Lumen Endotracheal Tube

An observational study in Intubation, Intratracheal and Multidetector Computed Tomography, sponsored by Javier H Campos. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-02-12.

Sponsored by Javier H Campos · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
101
Ages
18 Years to 90 Years
Sex
All
01

Study summary

One-lung ventilation (OLV) is used for thoracic surgical procedures to facilitate surgical exposure. Lung isolation is performed using a double-lumen endotracheal tube (DLT) and optimal position is achieved with the use of fiberoptic bronchoscopy. The most common technique used to place a left-sided DLT is the blind method technique, which consists of direct laryngoscopy and rotation of the DLT into the trachea with the aim to intubate the entrance of the left main bronchus. The DLT will be rotated counterclockwise blindly after the tip of the DLT passes the vocal cords under direct laryngoscopy. However, in some occasions, the tip of the DLT migrates into the right bronchus because the alignment between the trachea and right bronchus is more vertical. The identification of the misplacement can be challenging, which could lead to the failure of lung isolation. In order to avoid the unsuccessful lung isolation, Investigators are interested in identifying the factors that potentially influence the incorrect tube DLT placement diverting into the opposite bronchus.

Read the detailed description

Recently, multi-detector 3-dimensional computed tomography (MDCT) scan of the chest is becoming a routine study for patients requiring thoracic surgical procedures. On the day of thoracic surgery, the participant will be intubated with a left-sided DLT and investigators will confirm the correct insertion of the left-sided DLT at first pass under direct laryngoscopy. This information will be recorded and saved. After the study is completed, investigators will review the MDCT of the chest to review any abnormal findings and correlate it with the success of the insertion of the left-sided DLT into the left bronchus. Investigators will conduct a pilot study to determine the most influential anatomical change that leads to the DLT misplacement at the first pass based upon the changes of the tracheal-bronchial anatomy on MDCT.

02

Conditions studied

  • Intubation, Intratracheal
  • Multidetector Computed Tomography

Keywords

  • Double-lumen endotracheal tube
  • Multidetector Computed Tomography
03

In context

Lead sponsor

Javier H Campos is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patient undergoing scheduled thoracic surgery at University of Iowa Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years of age
  • Adult patient undergoing scheduled thoracic surgery which requires left side double lumen tube placement

Exclusion criteria

Exclusion Criteria:

  • More than 90 years of age
  • Patients with emergency surgery
  • Prisoners
  • Patients who cannot provide their own consent
  • Patient refusal
  • Non-English speaking patients
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
101 participants (actual)
Patient registry
No

Groups and cohorts

  • Left main bronchus (LMB) intubation

    Thoracic surgery patient is intubated with left side double lumen tube (L-DLT) and a fiberoptic bronchoscope is used to verify optimal positioning. The patient is designated as this group when the endobronchial lumen is observed to be in the left main bronchus (correct placement).

  • Right main bronchus (RMB) intubation

    Thoracic surgery patient is intubated with left side double lumen tube (L-DLT) and a fiberoptic bronchoscope is used to verify optimal positioning. The patient is designated as this group when the endobronchial lumen is observed to be in the right main bronchus (incorrect placement).

06

What researchers measure

Primary outcomes

  1. Measure tracheal length (mm) derived from MDCT images

    Participants are divided into two groups based upon the first pass location of the L-DLT; LMB (left main bronchus) intubation group and RMB (right main bronchus) intubation group. Tracheal length as seen on MDCT images will be measured (millimeters) and compared between the two groups.

    Time frame: Within 1 month

  2. Measure LMB diameter (mm) derived from MDCT images

    Participants are divided into two groups based upon the first pass location of the L-DLT; LMB (left main bronchus) intubation group and RMB (right main bronchus) intubation group. The LMB as seen on MDCT images will be measured (millimeters) and compared between the two groups.

    Time frame: Within 1 month

  3. Measure RMB diameter (mm) derived from MDCT images

    Participants are divided into two groups based upon the first pass location of the L-DLT; LMB (left main bronchus) intubation group and RMB (right main bronchus) intubation group. The RMB as seen on MDCT images will be measured (millimeters) and compared between the two groups.

    Time frame: Within 1 month

  4. Measure the tracheal LMB curvature (TLMBC) derived from MDCT images

    Participants are divided into two groups based upon the first pass location of the L-DLT; LMB (left main bronchus) intubation group and RMB (right main bronchus) intubation group. The TLMBC as seen on MDCT images will be measured and compared between the two groups. TLMBC is measured at the Trachea LMB branch point. The center lines of the airway segments (trachea and LMB) close to the branch point are displayed. A circumscribed circle goes through three adjacent airway points centered at the branch point is produced and the curvature is calculated by the reciprocal of the circle radius. The curvature of a straight line is zero. A larger curvature indicates a sharper turning angle.

    Time frame: Within 1 month

  5. Measure the tracheal RMB curvature (TRMBC) derived from MDCT images

    Participants are divided into two groups based upon the first pass location of the L-DLT; LMB (left main bronchus) intubation group and RMB (right main bronchus) intubation group. The TRMBC as seen on MDCT images will be measured and compared between the two groups. TRMBC is measured at the Trachea LMB branch point. The center lines of the airway segments (trachea and RMB) close to the branch point are displayed. A circumscribed circle goes through three adjacent airway points centered at the branch point is produced and the curvature is calculated by the reciprocal of the circle radius. The curvature of a straight line is zero. A larger curvature indicates a sharper turning angle.

    Time frame: Within 1 month

Secondary outcomes

  1. Calculate the TLMBC/TRMBC (TLMB/TRMB) Curvature Ratio

    Participants are divided into two groups based upon the first pass location of the L-DLT; LMB (left main bronchus) intubation group and RMB (right main bronchus) intubation group. A ratio of the TLMBC and TRMBC values reported above will be calculated and compared between the two groups.

    Time frame: Within 1 month

  2. Incidence of the DLT misplacement (RMB intubation) at the fast pass

    The number of times DLT misplacement (RMB intubation) at the first pass will be recorded.

    Time frame: Within 10 minutes

07

Study locations

1 site
  • University of Iowa Hospitals & Clinics
    Iowa City, Iowa 52242, United States
08

References and documents

Individual participant data

Plan to share: Yes — All of the individual participant data (IPD) collected during the trial, after de-identification will be shared with researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal. IPD will be available for sharing immediately after publication and ending 5 years following article publication.

Supporting information: Study protocol

Time frame: Individual participant data will be available for sharing immediately after publication and ending 5 years following article publication.

Access criteria: Individual participant data will be accessible to researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2012 to primary completion in Jun 2013, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2019
First posted
Feb 12, 2019
StartActual
Jul 20, 2012
Primary completionActual
Jun 19, 2013
CompletionActual
Jun 19, 2013
Last update
Feb 12, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03838653
Lead sponsor
Javier H Campos
Responsible party
Javier H Campos (Clinical Professor, University of Iowa) — Sponsor-investigator
First posted
Feb 12, 2019
Start date
Jul 20, 2012
Primary completion
Jun 19, 2013
Completion
Jun 19, 2013
Last update
Feb 12, 2019

Study contacts

Javier H Campos, MD
principal investigator · University of Iowa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion